DR. DEMAEGD JEROEN ANESTHESIE
0711.868.350 · rovalta.com · 27/09/2026
DR. DEMAEGD JEROEN ANESTHESIE
Financial year 2023 · Closed on 31/12/2023
Overview
Identity
Source · BCE/KBODR. DEMAEGD JEROEN ANESTHESIE is a Private limited company incorporated in 2018. Its main activity is: Specialist medical practice activities. Its registered office is in Zottegem.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0711.868.350
- Incorporation
- 18/10/2018
- Legal form
- Private limited company
- Registered office
- Vierwegenstraat 11
9620 Zottegem · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2023
Financials
Source · NBB, 5 filingsTrend over 5 financial years
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 271,5 k € | +52.0% | 178,5 k € | -10.4% | 199,3 k € | +14.1% | 174,8 k € | -19.5% | 217 k € |
| EBITDA | 270,6 k € | +52.5% | 177,4 k € | -10.6% | 198,5 k € | +14.1% | 173,9 k € | -19.5% | 216 k € |
| Operating result | 229,5 k € | +68.6% | 136,2 k € | -12.9% | 156,3 k € | +18.8% | 131,6 k € | -19.3% | 163,1 k € |
| Net result | 168,6 k € | +67.9% | 100,4 k € | -11.4% | 113,3 k € | +29.3% | 87,7 k € | +5.1% | 83,4 k € |
| Balance sheet | |||||||||
| Equity | 432 k € | +42.4% | 303,4 k € | +19.9% | 253 k € | +33.4% | 189,7 k € | +85.9% | 102 k € |
| Total assets | 498,2 k € | +25.2% | 397,8 k € | -10.2% | 443,1 k € | +1.4% | 436,9 k € | -1.3% | 442,7 k € |
| Cash | 6,4 k € | -95.7% | 149,9 k € | +19.3% | 125,7 k € | +95.5% | 64,3 k € | +316% | 15,5 k € |
| Debts | 66,2 k € | -26.1% | 89,6 k € | -52.9% | 190,2 k € | -23.1% | 247,2 k € | -27.4% | 340,7 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20231 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
Vierwegenstraat 11 9620 Zottegem| Company | CBE no. |
|---|---|
dr. Van Lierde Sybile MDZ● Active | 0795.831.055 |
Financials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 17/10/2018 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 15 months |
| Filing date | 31/07/2024 | 31/07/2023 | 04/07/2022 | 14/07/2021 | 08/06/2020 |
| General meeting | 01/06/2024 | 03/06/2023 | 04/06/2022 | 05/06/2021 | 06/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 5 filingsValuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20231 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 2023168,6 k €↑
- 2022Annual accounts 2022100,4 k €↓
- 2021Annual accounts 2021113,3 k €↑
- 2020Annual accounts 202087,7 k €↑
- 2019Annual accounts 201983,4 k €
- 18/10/2018IncorporationPrivate limited company